Read this company snapshot
Daily valuation snapshot
Q32 Bio Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $8.34
- Market capitalization (USD)
- $248,277,346.44
- Price / earnings (TTM)
- 7.35
- Price / book
- 2.34
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research QTTB in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research QTTB in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing QTTB with another company.
| Daily close (USD) | $8.34 |
| Market capitalization (USD) | $248,277,346.44 |
| Price / earnings (TTM) | 7.35 |
| Price / book | 2.34 |
No matching rows. Clear the filter to see all records.
Read QTTB's valuation metrics
Company size
Q32 Bio Inc. Common Stock's recorded market capitalization is $248,277,346.44. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
QTTB's recorded P/E is 7.35: about $7.35 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
QTTB's recorded price-to-book ratio is 2.34. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Q32 Bio Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about QTTB. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow QTTB's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.